Saturday, 5 September 2026European Markets

BARBARA BUI Stock Impressive Jump Before The Weekend, Outperforms Market

Loading stream...

(vianews) - the market ended the session with barbara bui (bui.pa) rising 20.83% to €8.70 on friday, following the last session's upward trend. cac 40 jumped 0.01% to €8,205.81, after three successive sessions in a row of gains, on what was a somewhat positive trend trading session today.

barbara bui's last close was €8.70, 17.14% below its 52-week high of €10.50.

about barbara bui

barbara bui sa engages in the manufacture, marketing, and sale of ready-to-wear clothing and accessories for women in france and internationally. the company offers coats, jackets, tops and shirts, t-shirts, mesh, pants, dresses and skirts, leather products, and tailored cloths; and accessories, such as shoes, bags, scarves, and belts. it offers its products through wholesale distributors, as well as online and offline stores. the company was incorporated in 1982 and is based in paris, france.

earnings per share

as for profitability, barbara bui has a trailing twelve months eps of €1.04.

pe ratio

barbara bui has a trailing twelve months price to earnings ratio of 8.37. meaning, the purchaser of the share is investing €8.37 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 125.51%.

volume

today's last reported volume for barbara bui is 314 which is 1265.22% above its average volume of 23.

more news about barbara bui (bui.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com